Background {#Sec1}
==========

Salivary gland malignant tumours account for 1--3% of head and neck cancers \[[@CR1]\]. Acinar cell carcinoma (ACC) is an uncommon malignant tumour, and its predominant site of origin is salivary glands in the head and neck region \[[@CR2]\]. Approximately 80% of ACC originates in the parotid gland; the remaining disease originates in the submandibular and sublingual glands, and there are reports involving the hypopharynx, lip, thyroid, tongue and tonsil \[[@CR3]\]. Head and neck ACC (HNACC) is mainly found in the salivary gland, and ACC accounts for only approximately 6% of all salivary gland neoplasms. Apart from mucoepidermoid carcinoma, adenocarcinoma, and adenoid cystic carcinoma, ACC is the fourth most common reported malignancy of the parotid gland. Given the rarity of the disease, data on the general demographics, clinical characteristics, treatment and prognosis of HNACC are still sporadic \[[@CR4]\].

There have been no controlled studies that define the optimal treatment for HNACC. The treatment modalities reported including surgical resection, radiotherapy and chemotherapy, and combined therapies with variable results \[[@CR3]\]. However, among all salivary gland cancers, HNACC has a relatively favourable prognosis \[[@CR5]\]. It is worth noting that, based on some researchers' institutional experience, HNACC is classified as a low-grade cancer regardless of its clinicopathologic features \[[@CR6]\]. Pathological differentiation (high grade vs low grade) is the only considered prognostic indicator \[[@CR7]\]. ACC has a tendency to recur locoregionally, to produce lymph node and distant metastasis, and to display aggressive evolution \[[@CR8]\].

For rare tumours, nationwide population-based retrospective analysis may make it possible to evaluate trends in demographic features, clinicopathologic characteristics, treatment modalities and disease-specific prognostic indicators. We conducted a comprehensive analysis of all primary HNACC cases registered in the Surveillance, Epidemiology, and End Results (SEER) database of the United States National Cancer Institute from 1975 to 2016.

Methods {#Sec2}
=======

Study population {#Sec3}
----------------

SEER\*Stat software developed by the National Cancer Institute (Surveillance Research Program, National Cancer Institute SEER\*Stat software 8.3.6; <https://seer.cancer.gov>) was used to extract the study cases. International Classification of Diseases for Oncology (ICD-O-3) codes for acinar cell carcinoma (8550/3) and head and neck topographic codes were used to identify cases with a diagnosis of HNACC registered in the SEER database. The variables in the analysis included marital status at diagnosis, insurance status, tumour orientation, age range, mean age, gender, race, pathological differentiation, American Joint Committee on Cancer (AJCC) stage, TNM stage, neck dissection, surgery, radiotherapy and chemotherapy. Our study used established data and did not involve interaction with human subjects. Therefore, institutional review board approval was not required.

Statistical analysis {#Sec4}
--------------------

Statistical analysis was performed using the statistical packages R (The R foundation; <http://www.r-project.org>; version 3.4.3), Empower R (<http://www.empowerstats.com>, Boston, Massachusetts), and the Statistical Package for the Social Sciences, Version 23.0, for Windows (SPSS, Chicago, IL). Differences in numerical variables were assessed using Student's t-test or the non-parametric Wilcoxon test. The chi square test or Fisher's exact test for categorical variables was used for two-group comparisons of parameters. Survival curves for different variable values were generated using Kaplan-Meier estimates and were compared using the log-rank test. Variables that achieved significance at *P* \< 0.05 were entered into the multivariable analyses via the Cox regression model.

Results {#Sec5}
=======

Summary statistics {#Sec6}
------------------

A total of 2624 primary HNACC cases were included in the study. The demographic and clinicopathological characteristics of the cases are summarized in Table [1](#Tab1){ref-type="table"}. There is a significant difference in gender distribution; 1052 of the cases are male, and 1572 are female. The mean age at diagnosis was 50 years for the total cohort and ranged from 5 to 96 years. According to this dataset, HNACC occurred in the lip, nose and nasal cavity, middle ear, eye and orbit, gum, floor of the mouth, tonsil, tongue, thyroid gland, oropharynx, nasopharynx, hypopharynx, larynx, pharynx, submandibular gland, sublingual gland and parotid gland. Among the total cohort, 2416 cases originated from salivary glands, including 2325 parotid gland ACC cases. White people accounted for 81% of the total population (2131/2624). With respect to pathological differentiation, definite pathological information was available for only 938 cases. Most of the cases were grade I and grade II; grade III plus IV carcinoma accounted for 12.3%. The percentages of cases with lymph node metastasis and distant metastasis were 7% (96/1351) and 6% (76/1183), respectively. Surgical resection was the primary treatment modality. Surgery was performed in 2516 patients, including 905 patients in which simultaneous neck dissection was performed, and 839 cases received surgery plus radiotherapy. Table 1The summary of HNACC patients' clinicopathologic characteristics**VariablesDisease specific survivalOverall survivalAliveDeadTotal*P*-valueAliveDeadTotal*P*-valueMarital status at diagnosis**Single568285960.000569696380.000Married1086129121510943551449Other status20456260204175379**Insurance status**Any Medicaid9481020.22494121060.837Insured8664491087378951Uninsured2833128533**Tumor orientation**Salivary gland184521020550.175185456224160.002Beyond salivary gland1381014814068208**Age age**0--1917101710.00017131740.00020--2924352482431025330--39323153383243435840--49398324303996646550--593964143739810350160--692885834629115244370--791193615512216328580+4533784699145**Gender**Female121011213220.004121935315720.000Male7731088817756301405**Race**Black193162090.003193452380.000White1570196176615795522131Others179718618130211**Pathological grade**Grade I407184250.000409714800.000Grade II2832030328459343Grade III + IV4256984273115**AJCC stage**Stage I53185390.000532355670.000Stage II3501236235328381Stage III + IV1736123417490264**AJCC T stage**T1656176730.000660567160.000T23712039137441415T3 + T41474819514872220**AJCC N stage**N010664911150.000107411311870.000N1321850322456N2 + N3161733162440NX6016160868**AJCC M stage**M011117211830.000111914712660.000M1 + M2631376632285**Neck dissection**No507225290.020510725820.608Yes79662858801104905**Radiotherapy**No13599814570.000136638917550.002Yes624122746628241869**Chemotherapy**No196620321690.000197761025870.000Yes171734172037**Treatment**Surgery13549614500.000136138617470.010Surgery+RT611107718615224839

### Survival analysis {#Sec7}

Kaplan-Meier analysis was performed for time-to-event analysis for overall survival (OS) and disease-specific survival (DSS). Regardless of confounding factors, 5-year, 10-year and 20-year OS was 90, 80 and 64%, respectively. Significant differences in OS were found depending on age range (*P* \< 0.0001), mean age (*P* \< 0.0001), marital status at diagnosis (*P* \< 0.0001), gender (*P* = 0.01), pathological differentiation (*P* \< 0.0001), race (*P* = 0.007), AJCC stage (*P* \< 0.0001), AJCC T stage (*P* \< 0.0001), AJCC N stage (*P* \< 0.0001), AJCC M stage (*P* \< 0.0001), surgery, (*P* \< 0.0001), radiotherapy (*P* \< 0.0001), chemotherapy (*P* \< 0.0001) and combined treatment modality (*P* \< 0.0001) (Fig. [1](#Fig1){ref-type="fig"}). Of the total cohort, 2203 patients were available for DSS analysis. The median follow-up time for these cases was 123 months (range, 1--503 months). Regardless of all other factors, 10-year and 20-year DSS was 93.6 and 90%, respectively, for patients who received surgery alone and 84.3 and 75.8%, respectively, for patients who received surgery plus radiotherapy (*P* \< 0.0001). In addition, statistically significant differences in DSS were found to be associated with age (*P* \< 0.0001), race (*P* = 0.007), mean age (*P* \< 0.0001), marital status at diagnosis (*P* \< 0.0001), gender (*P* = 0.007), AJCC stage (*P* \< 0.0001), AJCC T stage (*P* \< 0.0001), AJCC N stage (*P* \< 0.0001), AJCC M stage (*P* \< 0.0001), neck dissection (*P* = 0.024) and pathological differentiation (*P* \< 0.0001) (Fig. [2](#Fig2){ref-type="fig"}). Fig. 1Overall survival curves of cases with HNACC compared according to (**a**) age range, (**b**) mean age, (**c**) gender, (**d**) pathological grade, (**e**) race, (**f**) AJCC stage, (**g**) AJCC T stage, (**h**) AJCC N stage and (**i**) treatment modalities. Log-rank test was utilized to compare curves, and significance is presented on each panelFig. 2Disease specific survival curves of cases with HNACC compared according to (**a**) age range, (**b**) mean age, (**c**) material status, (**d**) gender, (**e**) AJCC N stage, (**f**) AJCC T stage, (**g**) AJCC stage, (**h**) neck dissection, and (**i**) treatment modalities. Log-rank test was utilized to compare curves, and significance is presented on each panel

Multivariate survival analysis was performed using the Cox proportional hazards regression model and the significant variables listed above. Surgical treatment was favourably associated with better DSS and OS \[HR (95% CI) = 0.13 (0.03--0.6), *P* = 0.0092; HR (95% CI) = 0.23 (0.07--0.79), *P* = 0.0203\]. Gender was the only demographic independent prognostic factor for both DSS and OS \[Male vs female, HR (95% CI) = 3.3 (1.51--7.22), *P* = 0.0028 for DSS; HR (95% CI) = 2.44 (1.05--5.64), *P* = 0.0376 for OS\]. Higher pathological grade was adversely associated with DSS and OS \[Grade II HR (95% CI) = 4.03 (1.04--15.7), *P* = 0.0444; Grade III + IV, HR (95% CI) = 35.64 (10.9--125.94), *P* = 0.0000 for DSS; Grade III + IV, HR (95% CI) = 4.49 (2.3--8.77), *P* = 0.0000 for OS, Grade I as reference\]. Details of the multivariate Cox regression analysis are presented in Fig. [3](#Fig3){ref-type="fig"}. Fig. 3Forest plots summarizing hazard ratios for (**a**) DSS and (**b**) OS

Discussion {#Sec8}
==========

With the exception of case reports and small retrospective case series, no adequate data describing HNACC demographics are available \[[@CR4], [@CR9], [@CR10]\]. In the current investigation, the gender incidence distribution showed a higher number of females than males, and there was a statistically significant predominance of HNACC in females (*P* \< 0.001). HNACC could be found at any age, and the mean age at diagnosis was 50 years. Previous research on HNACC is based on single institutional experiences, and because of the small sample size, those studies are often not sufficiently powerful to find considerable differences in survival that are related to general demographic parameters \[[@CR11]--[@CR13]\]. In the survival analysis in our study, significant differences in DSS and OS were found to be related to age range, mean age, gender, race and marital status (*P* \< 0.001). The most important findings regarding the demographics of HNACC are that gender and mean age are independent prognostic indicators for DSS and OS and that females under 50 years of age had more favourable prognosis than males over fifty.

TNM/AJCC staging plays an essential role in the planning of tumour treatment and in prognostic evaluation. The lymph node and distant metastasis rates of HNACC are low; the lymph node metastasis rate is less than 10%, and the distant metastasis rate is approximately 5 % \[[@CR14]\]. In this circumstance, AJCC T stage plays a crucial role in prognosis evaluation; the larger the volume of the tumour is, the worse the prognosis is. In our results, AJCC T3 + T4 stage is an adverse independent OS prognostic indicator. There is a question of whether elective neck dissection should be performed in HNACC patients. In our DDS analysis, HNACC patients did not benefit from elective neck dissection. Patients with and without elective neck dissection showed no statistically significant differences in OS or in the survival analysis of the pathological grade III + IV subgroup and the AJCC T3 + T4 stage subgroup. In view of the low frequency of metastases, routine elective treatment of the neck is not recommended. However, elective neck dissection should be considered in the treatment of large and high-grade tumours \[[@CR15]\].

In previous articles, pathological grade was used as an important prognostic reference \[[@CR6], [@CR16], [@CR17]\]. Consistent with earlier reports, our results indicate that pathological differentiation is the strongest prognostic indicator. Compared to well-differentiated Grade I HNACC cases, Grades II, III and IV are unfavourably associated with DSS and OS. The pathologic subtypes of ACC have been reported \[[@CR3], [@CR18]\]. Unfortunately, the effects of these variants on prognosis could not be established because of the limited data. HNACC was mainly found in the parotid gland, and surgical resection was the primary treatment modality. Unlike the rest of the head and neck region, because of the presence of the facial nerve, the orientation of parotid gland ACC determines the type of surgery that is performed (Partial parotidectomy, superficial parotidectomy or total parotidectomy). The choice of surgical type has a huge impact on the prognosis of patients with parotid gland malignancies \[[@CR19], [@CR20]\]. According to the distribution of sample size and site, we divided the study population into two groups: (a) parotid gland group and (b) beyond parotid gland group. The results of survival analysis show that there was no significant difference in the survival of these two groups. The SEER system does not provide detailed information about the location of parotid gland ACC or the type of surgery performed. Thus, we were unable to perform further analysis based on surgical type. In this cohort, 839 patients received radiotherapy; the prognosis of those patients was poor compared to that of patients who were treated with surgery alone. This result should be interpreted cautiously because in the clinical treatment of parotid gland ACC, radiotherapy is often implemented when adverse factors such as positive surgical margins or poor pathologic differentiation are present \[[@CR21]\].

Several important limitations of this study are acknowledged. First, this SEER-based investigation was a retrospective analysis with some inherent bias. Some crucial data such as surgical type, surgical margins, and details of neck dissection could not be obtained, restricting further analysis. A geographic bias could not be totally avoided because of the nonuniform distribution of the SEER registries. Second, retrospective SEER-based analysis depends on accurate coding and consistent data collection among numerous sites, both of which can be imprecise. Third, due to the lack of complete data on adjuvant therapy, the role of radiotherapy and chemotherapy could not be well established. Finally, the retrospective nature of the study and the incompleteness of the clinicopathological data may weaken the strength of our conclusions.

Conclusion {#Sec9}
==========

In summary, despite the limitations of the incomplete data and of the study itself, to the best of our knowledge the present study is the first investigation to use a large study population and a long follow-up time to define the clinicopathologic characteristics and identify the prognostic indicators of ACC in the head and neck region. Three earlier reports described ACC cases reported in the National Cancer Database and the SEER database \[[@CR2], [@CR5], [@CR14]\]. Although there is overlap among the study samples, the conclusions are complementary and enhance each other due to the different research intentions. Gender was the only demographic independent prognostic factor for both DSS and OS. With respect to treatment, surgical treatment was the only independent favourable prognostic factor for both DSS and OS. In addition, age, pathological differentiation, and TNM/AJCC stage were associated with DSS and OS.
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